BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 26156521)

  • 1. The Breast Cancer to Bone (B2B) Metastases Research Program: a multi-disciplinary investigation of bone metastases from breast cancer.
    Brockton NT; Gill SJ; Laborge SL; Paterson AH; Cook LS; Vogel HJ; Shemanko CS; Hanley DA; Magliocco AM; Friedenreich CM
    BMC Cancer; 2015 Jul; 15():512. PubMed ID: 26156521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel gene expression signature for bone metastasis in breast carcinomas.
    Savci-Heijink CD; Halfwerk H; Koster J; van de Vijver MJ
    Breast Cancer Res Treat; 2016 Apr; 156(2):249-59. PubMed ID: 26965286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic progression of breast cancer: insights from 50 years of autopsies.
    Cummings MC; Simpson PT; Reid LE; Jayanthan J; Skerman J; Song S; McCart Reed AE; Kutasovic JR; Morey AL; Marquart L; O'Rourke P; Lakhani SR
    J Pathol; 2014 Jan; 232(1):23-31. PubMed ID: 24122263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer.
    Carter RZ; Micocci KC; Natoli A; Redvers RP; Paquet-Fifield S; Martin AC; Denoyer D; Ling X; Kim SH; Tomasin R; Selistre-de-Araújo H; Anderson RL; Pouliot N
    J Pathol; 2015 Apr; 235(5):760-72. PubMed ID: 25430721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.
    Parker BS; Ciocca DR; Bidwell BN; Gago FE; Fanelli MA; George J; Slavin JL; Möller A; Steel R; Pouliot N; Eckhardt B; Henderson MA; Anderson RL
    J Pathol; 2008 Feb; 214(3):337-46. PubMed ID: 17985332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of metastatic behaviour of breast cancer subtypes.
    Savci-Heijink CD; Halfwerk H; Hooijer GK; Horlings HM; Wesseling J; van de Vijver MJ
    Breast Cancer Res Treat; 2015 Apr; 150(3):547-57. PubMed ID: 25820592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastases.
    Hohensee I; Lamszus K; Riethdorf S; Meyer-Staeckling S; Glatzel M; Matschke J; Witzel I; Westphal M; Brandt B; Müller V; Pantel K; Wikman H
    Am J Pathol; 2013 Jul; 183(1):83-95. PubMed ID: 23665199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast Osteoblast-like Cells: A Reliable Early Marker for Bone Metastases From Breast Cancer.
    Scimeca M; Antonacci C; Toschi N; Giannini E; Bonfiglio R; Buonomo CO; Pistolese CA; Tarantino U; Bonanno E
    Clin Breast Cancer; 2018 Aug; 18(4):e659-e669. PubMed ID: 29306659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Vitamin D Deficiency in Patients with Bone Metastases and Multiple Myeloma.
    Maier GS; Horas K; Kurth AA; Lazovic D; Seeger JB; Maus U
    Anticancer Res; 2015 Nov; 35(11):6281-5. PubMed ID: 26504063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of bone metastasis after early-stage breast cancer in Canada.
    Liede A; Jerzak KJ; Hernandez RK; Wade SW; Sun P; Narod SA
    Breast Cancer Res Treat; 2016 Apr; 156(3):587-595. PubMed ID: 27083181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
    Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
    Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bone microenvironment invigorates metastatic seeds for further dissemination.
    Zhang W; Bado IL; Hu J; Wan YW; Wu L; Wang H; Gao Y; Jeong HH; Xu Z; Hao X; Lege BM; Al-Ouran R; Li L; Li J; Yu L; Singh S; Lo HC; Niu M; Liu J; Jiang W; Li Y; Wong STC; Cheng C; Liu Z; Zhang XH
    Cell; 2021 Apr; 184(9):2471-2486.e20. PubMed ID: 33878291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study.
    Lawler K; Papouli E; Naceur-Lombardelli C; Mera A; Ougham K; Tutt A; Kimbung S; Hedenfalk I; Zhan J; Zhang H; Buus R; Dowsett M; Ng T; Pinder SE; Parker P; Holmberg L; Gillett CE; Grigoriadis A; Purushotham A
    Breast Cancer Res; 2017 Oct; 19(1):113. PubMed ID: 29029636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases.
    van der Pluijm G; Sijmons B; Vloedgraven H; Deckers M; Papapoulos S; Löwik C
    J Bone Miner Res; 2001 Jun; 16(6):1077-91. PubMed ID: 11393785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs.
    Capulli M; Angelucci A; Driouch K; Garcia T; Clement-Lacroix P; Martella F; Ventura L; Bologna M; Flamini S; Moreschini O; Lidereau R; Ricevuto E; Muraca M; Teti A; Rucci N
    J Bone Miner Res; 2012 Nov; 27(11):2387-98. PubMed ID: 22714395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms and pathways of bone metastasis: challenges and pitfalls of performing molecular research on patient samples.
    Cawthorn TR; Amir E; Broom R; Freedman O; Gianfelice D; Barth D; Wang D; Holen I; Done SJ; Clemons M
    Clin Exp Metastasis; 2009; 26(8):935-43. PubMed ID: 19697143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastases.
    Doot RK; Muzi M; Peterson LM; Schubert EK; Gralow JR; Specht JM; Mankoff DA
    J Nucl Med; 2010 Apr; 51(4):521-7. PubMed ID: 20237040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of vascular endothelial growth factor--a gene polymorphisms and haplotypes with breast cancer metastases.
    Langsenlehner U; Hofmann G; Renner W; Gerger A; Krenn-Pilko S; Thurner EM; Krippl P; Langsenlehner T
    Acta Oncol; 2015 Mar; 54(3):368-76. PubMed ID: 25152223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.